Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
No pharmaceutical company has filed an IND application disclosed in the public record
We commonly use BPC-157 as part of our treatment for the following conditions: Chronic gastrointestinal (GI) issues, including colitis, Crohns disease, irritable bowel disease (IBD), gastritis, ulcers, and esophagitis
The presence of BPC-157 might have led to an increased expression of VEGF-a, a variant of VEGF, and consequently accelerated the formation of vascular tubes in a laboratory setting
Benefits BPC-157 offers a wide range of benefits that make it valuable for patients dealing with injuries, chronic conditions, or gastrointestinal concerns
No study has definitively shown BPC-157 causes cancer in humans, and no vascular tumors have been observed in animal models with prolonged use
Animal toxicology studies found no acute toxicity, organ damage, or reproductive toxicity across multiple routes and doses, but these studies lasted only up to 6 weeks
US$ 26.71
US$ 22.47
US$ 22.62
US$ 24.22
US$ 29.13
